More evidence that TRT is safe for men after surgery for prostate cancer in this study:
"850 patients underwent radical prostatectomy by a single surgeon. All patients had preoperative testosterone and sex hormone binding globulin levels drawn; free testosterone was calculated prospectively.152 (18%) patients with low preoperative calculated free testosterone levels and delayed post‐operative sexual function recovery were placed on testosterone therapy and proportionately matched to 419 control patients by pathologic Gleason Grade Group and stage.
"Median follow‐up was 3.5 years. patients on testosterone therapy were approximately 54% less likely to recur. In men destined to recur, testosterone therapy delayed time to recurrence by an average of 1.5 years."
"850 patients underwent radical prostatectomy by a single surgeon. All patients had preoperative testosterone and sex hormone binding globulin levels drawn; free testosterone was calculated prospectively.152 (18%) patients with low preoperative calculated free testosterone levels and delayed post‐operative sexual function recovery were placed on testosterone therapy and proportionately matched to 419 control patients by pathologic Gleason Grade Group and stage.
"Median follow‐up was 3.5 years. patients on testosterone therapy were approximately 54% less likely to recur. In men destined to recur, testosterone therapy delayed time to recurrence by an average of 1.5 years."
